Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities

Allergan isn’t the only company expanding its footprint in Europe. Merck KGaA, Darmstadt, Germany plunked down $275 million to open a facility in Corsier-sur-Vevey, Switzerland, The Biotech Development Center will focus on biotech development and manufacturing for clinical studies. According to the report, the new facility will “help to sustainably secure capacity and high agility to deliver clinical trial material in a cost-effective way, contribute to accelerated development timelines of new biological entities, and address the increasing manufacturing complexity of the next generations of biotech compounds.”